Popular on eTradeWire
- enCloud9 Partners with ClickDimensions to Launch PowerPack, Revolutionizing Sales and Marketing for SMBs - 256
- Gravic, Inc. is Pleased to Announce the General Availability of HPE NonStop Shadowbase Version 6.801 - 235
- 2019 Hyundai Sonata for Sale in The Heart of Toronto - 233
- Community Comes Together for Unforgettable Back-to-School Bash at The CENTER @Joshua Home - 227
- BOWA Gives Girls' Invite track and field competition to be held in Chicago's Pullman neighborhood - 219
- Greater Fort Myers Chamber's Nov. 14 luncheon to celebrate Leadership Fort Myers 2023 graduates - 208
- Atlanta's most famous rug store founder advocates a hands-on-approach to rug shopping - 178
- Amazing Public Art Sculpture Created From Found Objects - 154
- Instantly Boost Your Website Organic Traffic with Premium Websites - 154
- JS Fun Event Hire Supplies Custom Cash Grabber for Pringles' Movember - 152
Similar on eTradeWire
- Revolutionizing sustainability with a plant-based gold leaching solution and technology to recover gold from ore while reducing environmental impact
- Dr. George Sepiashvili Was Just Interviewed By Randy Alvarez On The Wellness Hour TV Show!
- QinFlow & First Responders Stand Behind Ukraine!
- TekTone® Donates to Macon County Public Health in Honor of Breast Cancer Awareness
- Evara Health Foundation receives a substantial gift of $7.5M from MacKenzie Scott
- AVTECH's Room Alert Environment Monitoring Platform Earns Top Honors in 2023 Smart Buildings Innovation Awards
- Champion Awards Acknowledge Yaskawa's Dedicated Support for the ARM Institute
- Local Med-tech Company, Bedfont Scientific Ltd., Celebrates Double Triumph at the KICC Awards
- National Widowers Organization Announces Appointment of Eric Washington to the Board of Directors
- 2024 is around the corner for Independent Pharmacies
Xheme Adds Industry-Leading Pharma R&D Executive and Precision Medicine Market Place Pioneer to Team
eTradeWire News/10742361
Julia Rashba-Step, Ph.D. and Max Narovlyansky, Ph.D. join the leadership team of Xheme, a specialty materials company developing eco-friendly multifunctional additives for bioprocessing, sustainable plastics, and coatings.
NEWTON, Mass. - eTradeWire -- Xheme, Inc., a specialty materials company developing eco-friendly multifunctional additives for bioprocessing, sustainable plastics, and coatings, today announced that Julia Rashba-Step, Ph.D. and Max Narovlyansky, Ph.D. are joining Xheme's leadership team.
Dr. Julia Rashba-Step is a senior pharmaceutical professional with an extensive background in biotechnology, nanotechnology, and pharmaceutical industries. Her primary focus is to lead Xheme's relationships with bioprocessing companies, build strategic commercialization partnerships, and develop the licensing framework for Xheme technologies.
Dr. Rashba-Step was most recently the Vice President of Research & Development and Alliance Management at Phosphorex. Passionate about advancing cutting edge innovative technologies into clinical stage programs and the commercial space, she previously held formulation and delivery leadership positions at Pfizer, Baxter Healthcare, and Wyeth BioPharma, as well as at start-ups including Epic Therapeutics. She received her Ph.D. in Biophysics from the Russian Academy of Sciences. Dr. Rashba-Step is currently serving as an advisor to a number of bio-pharmaceutical companies and will also be the newest member of Xheme's Advisory Board.
More on eTradeWire News
"I am excited to be joining the Xheme team at a pivotal juncture in the company's trajectory," said Dr. Rashba-Step. "A potent catalyst and antioxidant agent, Xheme's additive technology holds potential for applications across various industries, including bioprocessing. I firmly believe that my experience in nanotechnology, biotechnology and oxidative stress positions me to advance Xheme to new heights and guide it towards its next phase of growth and success."
Additionally, Dr. Max Narovlyansky, founder of FlowCell and an expert in the design, manufacture, and use of medical devices, will be joining Xheme's leadership team as Senior Scientist. Most recently the CEO of FlowCell, Narovlyansky formerly served as the Director of Assay Development at Eutropics Pharmaceuticals and held scientist positions at Werfen North America and Abbott. With his specialized knowledge in point-of-care devices and experience with the regulatory environment, Dr. Narovlyansky will support product development, analysis, and clinical testing, as well as manage federal grants. He holds a Ph.D. in Biochemistry from Harvard University.
"I am very excited to be joining the Xheme team that has developed nano-structured particles and to apply this powerful platform to biological applications, such as addressing storage and transportation of biological materials that is in increasing demand due to prevalence of modern therapy options involving biologicals or cells," Dr. Narovlyansky. "I look forward to working with this great team, their scientific and industrial collaborators in tackling exciting multi-faceted challenges of optimizing, packaging, and validating these novel materials for life science applications, such as storage of blood and platelets and bio-processing."
More on eTradeWire News
"The expansion of our leadership team with Julia and Max marks a significant milestone for Xheme," said Kumar Challa, Ph.D., Co-founder, CSO, and President of Xheme. "The addition of their expertise will help us achieve our ambitious vision of developing non-toxic, sustainable additives that transform the bioprocessing, plastics, and coatings industries."
"I am delighted to welcome both Dr. Rashba-Step and Dr. Narovlyansky to the Xheme team."
About Xheme, Inc.
Xheme, Inc. is a specialty materials company based in Newton, MA. Xheme (pronounced EX-heem) is working to revolutionize the world of plastics and coatings applications by eliminating the need for single-use/single-function additives by using one programmable additive that provides the same, or better, performance. From bioprocessing bags to paints, the non-toxic Xheme Multifunctional Additive (XMA) provides a combination of four protections—from oxidation, UV, corrosion, and microbial contamination—and is safe for both people and the planet. Xheme has a robust intellectual property portfolio and is transforming discovery of next generation smart additives through collaborations with global academic and industry leaders. For more information, visit xheme.bio and follow us on LinkedIn.
Dr. Julia Rashba-Step is a senior pharmaceutical professional with an extensive background in biotechnology, nanotechnology, and pharmaceutical industries. Her primary focus is to lead Xheme's relationships with bioprocessing companies, build strategic commercialization partnerships, and develop the licensing framework for Xheme technologies.
Dr. Rashba-Step was most recently the Vice President of Research & Development and Alliance Management at Phosphorex. Passionate about advancing cutting edge innovative technologies into clinical stage programs and the commercial space, she previously held formulation and delivery leadership positions at Pfizer, Baxter Healthcare, and Wyeth BioPharma, as well as at start-ups including Epic Therapeutics. She received her Ph.D. in Biophysics from the Russian Academy of Sciences. Dr. Rashba-Step is currently serving as an advisor to a number of bio-pharmaceutical companies and will also be the newest member of Xheme's Advisory Board.
More on eTradeWire News
- What To Inspect When Buying A Used Car
- Who Has Been Distracted During Work or Athletics, from Debris falling Between the Shoe and Sock
- Exel Solar U.S. Emerges in response to Growing Solar Demand
- Revolutionizing sustainability with a plant-based gold leaching solution and technology to recover gold from ore while reducing environmental impact
- Local Microschool Wins National Recognition
"I am excited to be joining the Xheme team at a pivotal juncture in the company's trajectory," said Dr. Rashba-Step. "A potent catalyst and antioxidant agent, Xheme's additive technology holds potential for applications across various industries, including bioprocessing. I firmly believe that my experience in nanotechnology, biotechnology and oxidative stress positions me to advance Xheme to new heights and guide it towards its next phase of growth and success."
Additionally, Dr. Max Narovlyansky, founder of FlowCell and an expert in the design, manufacture, and use of medical devices, will be joining Xheme's leadership team as Senior Scientist. Most recently the CEO of FlowCell, Narovlyansky formerly served as the Director of Assay Development at Eutropics Pharmaceuticals and held scientist positions at Werfen North America and Abbott. With his specialized knowledge in point-of-care devices and experience with the regulatory environment, Dr. Narovlyansky will support product development, analysis, and clinical testing, as well as manage federal grants. He holds a Ph.D. in Biochemistry from Harvard University.
"I am very excited to be joining the Xheme team that has developed nano-structured particles and to apply this powerful platform to biological applications, such as addressing storage and transportation of biological materials that is in increasing demand due to prevalence of modern therapy options involving biologicals or cells," Dr. Narovlyansky. "I look forward to working with this great team, their scientific and industrial collaborators in tackling exciting multi-faceted challenges of optimizing, packaging, and validating these novel materials for life science applications, such as storage of blood and platelets and bio-processing."
More on eTradeWire News
- Best Freelance Copywriting Services
- "Street Fighter™ 6" Panel Announced for December 2nd at Los Angeles Comic Con; The Music of Street Fighter 6: A Special Look at the Video Game
- Industry Standard Warehouse Racking Melbourne - Outer Space Installs
- Merry Melrose at the Melrose Trading Post!
- After The Ink Dries - Will Savers Launches The First Physical Will & Trust Storage Service
"The expansion of our leadership team with Julia and Max marks a significant milestone for Xheme," said Kumar Challa, Ph.D., Co-founder, CSO, and President of Xheme. "The addition of their expertise will help us achieve our ambitious vision of developing non-toxic, sustainable additives that transform the bioprocessing, plastics, and coatings industries."
"I am delighted to welcome both Dr. Rashba-Step and Dr. Narovlyansky to the Xheme team."
About Xheme, Inc.
Xheme, Inc. is a specialty materials company based in Newton, MA. Xheme (pronounced EX-heem) is working to revolutionize the world of plastics and coatings applications by eliminating the need for single-use/single-function additives by using one programmable additive that provides the same, or better, performance. From bioprocessing bags to paints, the non-toxic Xheme Multifunctional Additive (XMA) provides a combination of four protections—from oxidation, UV, corrosion, and microbial contamination—and is safe for both people and the planet. Xheme has a robust intellectual property portfolio and is transforming discovery of next generation smart additives through collaborations with global academic and industry leaders. For more information, visit xheme.bio and follow us on LinkedIn.
Source: Xheme, Inc.
0 Comments
Latest on eTradeWire News
- 16th Annual Friends and Family Sale announced by LabNaturals, retailer of CBD, non-toxic skincare, and glutathione, based in Western Pennsylvania
- Invenio IT unites with Field Effect to deliver powerful cybersecurity to the SMB
- Kaiser Consulting Awarded a #1 Spot in Central Ohio's 2023 Best Places to Work
- Unlock Healing Today and Put Trauma in Its Place!
- BYD | RIDE Supports Women in Transportation with $5,000 Build Your Dreams Scholarship
- London Bay Development Group presenting sponsor for Guadalupe Center's 'Elevate' gala
- Titan Pressure Washing Demonstrates the Difference Between a Pressure Wash and a Soft Wash on Tile Roofs
- New Book, "Drink Like a Local," Unlocks The Spirits and Secrets of New Orleans Drinking Culture
- Altercare Locations Earn U.S. News & World Report's Best Nursing Homes Award
- National Minority Health Association Launches "Equity for All."
- Final Week For Medicare Insurance Open Enrollment
- Michael Corso Honored for His Legacy of Service and Patriotism
- Fred Haas Toyota World Presents the Battle For The Billboard Tundra Edition
- 'Stranger Things' Star Joseph Quinn Added to FAN EXPO Portland Lineup
- Cecilia Russo Marketing Awards $15,000 of Grants to Three Georgia Small Businesses
- Holabird's Christmas Chronicles auction, Dec. 7-10, online and live in Reno, is packed with over 2,500 lots
- Klarinet Solutions Recognized as Staffbase's Rising Star of the Year
- L-Tron to Attend Fire Chief Association (IAFC)Technology Summit International
- Lanier Islands Invites Atlanta to Enjoy Dinner with Santa and More
- Why Should I Provide Credit Card Payment Solutions at My Business?